Litigation and Compliance Impacts of Proposed Ethylene Oxide Regulations Based on Flawed Science
publication | June 2, 2024
Firm partners Robert E. Johnson and Aleksandra Rybicki address
- carcinogenicity of ethylene oxide;
- ethylene oxide regulatory framework;
- EPA’s flawed 2016 IRIS assessment;
- risk assessments should not be used to prove causation at trial;
- attacking plaintiffs’ corporate conduct themes;
- demystifying plaintiffs’ one-molecule theory;
- educating the jury about cancer and genotoxicity
Robert Johnston led and Aleksandra Rybicki was a member of the firm’s trial team that secured the first defense verdict in a case alleging that exposure to ethylene oxide caused cancer. They co-authored this article for DRI’s For the Defense.